Minocycline protects oligodendroglial precursor cells against injury caused by oxygen-glucose deprivation

Journal of Neuroscience Research

Volumn 90, Issue 5, 2012, Pages 933-944

  Schmitz, Thomas ^a   Endesfelder, Stefanie ^a   Chew, Li Jin ^b   Zaak, Irina ^a   Bührer, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Hypoxia ischemia; Neuroprotection; Oligodendrocyte progenitors; Oxidative stress

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLUCOSE; MANGANESE SUPEROXIDE DISMUTASE; MINOCYCLINE; MYELIN BASIC PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; OXYGEN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR SOX10;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; CELL MATURATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VITRO STUDY; NICK END LABELING; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; FEMALE; GANGLIOSIDES; GENE EXPRESSION REGULATION; GLUCOSE; KI-67 ANTIGEN; MINOCYCLINE; MYELIN BASIC PROTEINS; O ANTIGENS; OLIGODENDROGLIA; OXIDATIVE STRESS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84858008123     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22824     Document Type: Article

References (68)

1. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. 2002. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 52: 54-61.
2. Back SA, Gan XD, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neuosci 18: 6241-6253.
3. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin KL, Holtzman DM. 2002. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 22: 455-463.
4. Back SA, Riccle A, McClure MM. 2007. Maturation-dependent vulnerability of perinatal white matteer in premature birth. Stroke 38: 724-730.
5. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. 1989. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb use in the analysis of oligodendrocyte development. J Neurosci Res 24: 548-557.
6. Baud O, Haynes RF, Wang H, Folkerth RD, Li J, Volpe JJ, Rosenberg PA. 2004. Developmental up-regulation of McSOD in rat oligodendrocytes confers protection against oxidative injury. Eur J Neurosci 20: 29-40.
7. Bruno M, Goldberg MP, Dugan LL, Giffard RG, Choi DW. 1994. Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen-glucose deprivation or excitatory amino acids. J Neurochem 63: 1398-1406.
8. Buller KM, Carty ML, Reinebrant HE, Wixey JA. 2009. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate? J Neurosci Res 87: 599-608.
9. Cai Z, Lin S, Fan LW, Pang Y, Rhodes PG. 2006. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 137: 425-435.
10. Cai ZY, Yan Y, Chen R. 2010. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neurosci Bull 26: 28-36.
11. Carloni S, Carnevali A, Cimino M, Balduini W. 2007. Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat. Neurobiol Dis 27: 354-361.
12. Carty ML, Wixey JA, Colditz PB, Buller KM. 2008. Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. Int J Dev Neurosci 26: 477-485.
13. Cengiz P, Uluc K, Kendigelen P, Akture E, Hutchinson E, Song C, Zhang L, Lee J, Budoff GE, Meyerand E, Sun D, Ferrazzano P. 2011. Chronic neurological deficits in mice after perinatal hypoxia and ischemia correlate with hemispheric tissue loss and white matter injury detected by MRI. Dev Neurosci [Jun 24 E-pub ahead of print].
14. Cho KO, La HO, Cho YJ, Sung KW. 2006. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J Neuosci Res 83: 285-291.
15. Curtis R, Cohen J, Fok-Seang J, Hanley MR, Gregson NA, Reynolds R, Wilkin GP. 1988. Development of macroglial cells in rat cerebellum. I. Use of antibodies to follow early in vivo development and migration of oligodendrocytes. J Neurocytol 17: 43-54.
16. Deng W, Rosenberg PA, Volpe JJ, Jensen FE. 2003. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci U S A 100: 6801-6806.
17. Diguet E, Fernagut P-O, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F. 2004. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 19: 3266-3276.
18. Fan LW, Pang Y, Lin S, Tien LT, Ma T, Rhodos PG, Cai Z. 2005. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J Neurosci Res 82: 71-82.
19. Felderhoff-Mueser U, Sifringer M, Pesditschek S, Kuckuck H, Moysich A, Bittigau P, Ikonomidou C. 2002. Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol Dis 11: 231-245.
20. Finzsch M, Stolt CC, Lommes P, Wegner M. 2008. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development 135: 637-646.
21. Folkerth RD. 2006. Periventricular leukomalacia: overview and recent findings. Pediatr Dev Pathol 9: 3-13.
22. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. 2000. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 20: 9235-9241.
23. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE. 2004. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24: 4412-4420.
24. French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB. 2009. Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res 87: 3076-3087.
25. Fujimura M, Morita-Fujimura Y, Kawase M, Copin JC, Calagui B, Epstein CJ, Chan PH. 1999. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci 19: 3414-3422.
26. Gallo V, Armstrong RC. 1995. Developmental and growth factor induced regulation of nestin in oligodendrocyte lineage cells. J Neurosci 15: 394-406.
27. Gallo V, Zhou JM, McBain CJ, Wright P, Knutson PL, Armstrong RC. 1996. Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K1 channel block. J Neurosci 16: 2659-2670.
28. Goldberg MP, Choi DM. 1993. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 13: 3510-3524.
29. Hamel P, Abed E, Brissette L, Moreau R. 2008. Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells. Am J Physiol Cell Physiol 294: C1021-C1033.
30. Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC. 2003. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 62: 441-450.
31. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. 2000. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407: 390-395.
32. Iijima T. 2006. Mitochondrial membrane potential and ischemic neuronal death. Neurosci Res 55: 234-243.
33. Johnson MV, Hoon AH. 2006. Cerebral palsy. Neuromol Med 8: 432-450.
34. Kim HS, Suh YH. 2009. Minocycline and neurodegenerative diseases. Behav Brain Res 196: 168-179.
35. Kinney HC, Back SA. 1998. Human oligodendrocyte development: relationship to periventricular leucomalacia. Semin Pediatr Neurol 5: 180-189.
36. Kuang X, Scofield VL, Yan M, Stoica G, Liu N, Wong PK. 2009. Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice. Brain Res 1286: 174-184.
37. Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, Anca-Hershkowitz MS. 2007. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69: 1404-1410.
38. Lee CF, Chen YC, Liu CY, Wei YH. 2006. Involvement of protein kinase C delta in the alteration of mitochondrial mass in human cells under oxidative stress. Free Radic Biol Med 40: 2136-2146.
39. Levi G, Gallo V, Ciotti MT. 1986. Bipotential precursors of putative fibrous astrocytes and oligodendrocytes in rat cerebellar cultures express distinct surface features and "neuron-like" GABA transport. Proc Natl Acad Sci U S A 83: 1504-1508.
40. Leviton A, Dammann O. 2004. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res 55: 541-545.
41. Li D, Qu Y, Mao M, Zhang X, Li J, Ferriero D, Mu D. 2009. Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia. J Cereb Blood Flow Metab 29: 1903-1913.
42. Maire CL, Wegener A, Kerninon C, Nait Oumesmar B. 2010. Gain-of-function of Olig transcription factors enhances oligodendrogenesis and myelination. Stem Cells 28: 1611-1622.
43. Matsukawa N, Yasuhara T, Hara K, Xu L, Maki M, Yu G, Kaneko Y, Ojika K, Hess DC, Borlongan CV. 2009. Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci 10: 126.
44. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
45. Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Höglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. 2007. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 104: 4694-4699.
46. Noraberg J, Poulsen FR, Blaabjerg M, Kristensen BW, Bonde C, Montero M, Meyer M, Gramsbergen JB, Zimmer J. 2005. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord 4: 435-452.
47. Noshita N, Sugawara T, Fujimura M, Morita-Fujimura Y, Chan PH. 2001. Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice. J Cereb Blood Flow Metab 21: 557-567.
48. Orsucci D, Calsolaro V, Mancuso M, Siciliano G. 2009. Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. FEBS J 265: 1729-1738.
49. Pan Z, Perez-Polo R. 1993. Role of nerve growth factor in oxidant homeostasis: glutathione metabolism. J Neurochem 61: 1713-1721.
50. Pozniak CD, Langseth AJ, Dijkgraaf GJ, Choe Y, Werb Z, Pleasure SJ. 2010. Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing Suppressor of Fused expression. Proc Natl Acad Sci U S A 107: 21795-21800.
51. Prasad SS, Russell M, Nowakowska M. 2011. Neuroprotection induced in vitro by ischemic preconditioning and postconditioning: modulation of apoptosis and PI3K-Akt pathways. J Mol Neurosci 43: 428-442.
52. Russell JC, Whiting H, Szuflita N, Hossain MA. 2008. Nuclear translocation of X-linked inhibitor of apoptosis (XIAP) determines cell fate after hypoxia ischemia in neonatal brain. J Neurochem 106: 1357-1370.
53. Schildknecht S, Pape R, Müller N, Robotta M, Marquardt A, Bürkle A, Drescher M, Leist M. 2011. Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. J Biol Chem 286: 4991-5002.
54. Segovia KN, McClure M, Moravec M, Luo NL, Wan Y, Gong X, Riddle A, Craig A, Struve J, Sherman LS, Back SA. 2008. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 63: 520-530.
55. Silbereis JC, Huang EJ, Back SA, Rowitch DH. 2010. Towards improved animal models of neonatal white matter injury associated with cerebral palsy. Dis Models Mech 3: 678-688.
56. Skripuletz T, Miller E, Moharregh-Khiabani D, Blank A, Pul R, Gudi V, Trebst C, Stangel M. 2010. Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem Res 35: 1422-1433.
57. Taglialatela G, Perez-Polo JR, Rassin DK. 1998. Induction of apoptosis in the CNS during development by the combination of hyperoxia and inhibition of glutathione synthesis. Free Radi Biol Med 25: 936-942.
58. Tanaka S, Takehashi M, Iida S, Kitajima T, Kamanaka Y, Stedeford T, Banasik M, Ueda K. 2005. Mitochondrial impairment induced by poly (ADP-ribose) polymerase-1 activation in cortical neurons after oxygen and glucose deprivation. J Neurochem 95: 179-190.
59. Tang M, Alexander H, Clark RS, Kochanek PM, Kagan VE, Bayir H. 2010. Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest. J Cereb Blood Flow Metab 30: 119-129.
60. Thorburne SK, Juurlink BH. 1996. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 67: 1014-1022.
61. Volpe JJ. 1997. Brain injury in the premature infant-from pathogenesis to prevention. Brain Dev 19: 519-534.
62. Volpe JJ. 2009. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 8: 110-124.
63. Wang LY, Cai WQ, Chen PH, Deng QY, CM Z. 2009. Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia. Glia 57: 307-319.
64. Yuan X, Eisen AM, McBain CJ, Gallo V. 1998. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125: 2901-2914.
65. Zabad RK, Metz LM, Todoruk TR, Zhang Y, Mitchell JR, Yeung M, Patry DG, Bell RB, Yong VW. 2007. The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult Scler 13: 517-526.
66. Zemlyak I, Brooke SM, Singh MH, Sapolsky RM. 2009. Effects of overexpression of antioxidants on the release of cytochrome c and apoptosis-inducing factor in the model of ischemia. Neurosci Lett 453: 182-185.
67. Zhang H, Zhao D, Wang Z, Zheng D. 2010. Diazoxide preconditioning alleviates caspase-dependent and caspase-independent apoptosis induced by anoxia-reoxygenation of PC12 cells. J Biochem 148: 413-421.
68. Zhou Q, Anderson DJ. 2002. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109: 61-73.